ERBB2 and breast cancer: That these data are derived from a genetically distinct model (MMTV-erbB2 mouse) may be a compelling concern for a population at risk, that is, women with HER2/neu overexpressing breast cancer, who account for 15–30% of all women diagnosed with breast cancer.